Correlation between numeric gadolinium-enhanced dynamic MRI ratios and prognostic factors and histologic type of breast carcinoma

American Journal of Roentgenology

Volumn 187, Issue 2, 2006, Pages 297-306

  Narisada, Hiroyuki ^a   Aoki, Takatoshi ^a   Sasaguri, Takakazu ^a   Hashimoto, Hiroshi ^a   Konishi, Tetsumi ^a   Morita, Masaru ^a   Korogi, Yukunori ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Breast cancer; Dynamic MRI; MRI

Indexed keywords

CD31 ANTIGEN; CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST FIBROSIS; CANCER SURGERY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MICROVASCULATURE; MUCINOUS CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33746618327     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.0696     Document Type: Article

References (29)

1. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA: preliminary observations. Radiology 1989; 170:681-686
2. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196:115-122
3. Sardanelli F, Rescinito G, Giordano GD, Calabrese M, Parodi RC. MR dynamic enhancement of breast lesions: high temporal resolution during the first-minute versus eight-minute study. J Comput Assist Tomogr 2000; 24:724-731
4. Kuhl CK, Mielcarek P, Klaschik S, et al. Dynamic breast MR imaging: are signal time course data useful for differential diagnosis of enhancing lesions in dynamic breast MR imaging? Radiology 1999; 211:101-110
5. Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190:485-493
6. Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O, Kudo S. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000; 217:841-848
7. Mussurakis S, Gibbs P, Horsman A. Peripheral enhancement and spatial contrast uptake heterogeneity of primary breast tumours: quantitative assessment with dynamic MRI. J Comput Assist Tomogr 1998; 22:35-46
8. Sherif H, Mahfouz AE, Oellinger H, et al. Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 1997; 205:209-213
9. Buadu LD, Murakami J, Murayama S, et al. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis. J Comput Assist Tomogr 1997; 21:421-430
10. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200:639-649
11. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197:387-395
12. Mussurakis S, Buckley DL, Horsman A. Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 1997; 70:446-451
13. Fischer U, Kopka L, Brinck U, Korabiowska M, Schauer A, Grabbe E. Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. Eur Radiol 1997; 7:1002-1005
14. Robbins P, Pinder S, de Klerk N, et al. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 1995; 26:873-879
15. Hasebe T, Tsuda H, Hirohashi S, et al. Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. Jpn J Cancer Res 1996; 87:385-394
16. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501
17. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echoplanar MR imaging. Radiology 1995; 197:33-38
18. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced turboFLASH subtraction technique. Radiology 1994; 193:777-781
19. Fobben ES, Rubin CZ, Kalisher L, et al. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 1995; 196:143-152
20. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8
21. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340:1120-1124
22. Jitsuiki Y, Hasebe T, Tsuda H, et al. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast. Mod Pathol 1999; 12:492-498
23. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A. Tumour development, histology and grade of breast cancers: prognosis and progression. Int J Cancer 1996; 66:413-419
24. Andre S, Cunha F, Bernardo M, Sousa JME, Cortez F, Soares J. Mucinous carcinoma of the breast: a pathologic study of 82 cases. J Surg Oncol 1995; 58:162-167
25. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. Part 1. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19:403-410
26. Pinder SE, Murray S, Ellis IO, et al. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 1998; 83:1529-1539
27. Amat S, Penault-Llorca F, Cure H, et al. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy. Int J Oncol 2002; 20:791-796
28. Colpaert C, Vermeulen P, van Beest P, et al. Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients. Histopathology 2001; 39:416-425
29. Colpaert C, Vermeulen P, Jeuris W, et al. Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol 2001; 193:442-449